Human Embryonic Stem Cells (hESC)

Through numerous collaborations between the basic and clinical sciences across campus, faculty have demonstrated the ability to make new hESC lines and engineer cell differentiation. Dr. Amander Clark leads the BSCRC’s efforts in generating new hESC lines. In April 2010 the NIH accepted three UCLA hESC lines into its registry, allowing the cell lines to be used in federally funded research and increasing the diversity of cell lines available for study. As of April 2010, UCLA is one of only nine institutions in the world with stem cell lines admitted to the NIH registry.